期刊文献+

反义寡核苷酸联合磁性载药微球靶向治疗耐药裸鼠人胰腺癌 被引量:1

Reversal of multidrug resistance antisense oligodeoxynucletedes and 5-fluorouracil magnetic albu-min miscrospheres on human pancreatic carcinoma model in nude mice
原文传递
导出
摘要 目的观察辐射及多药耐药基因逆转剂反义寡核苷酸(mdr1ASON)联合5一氟尿嘧啶磁性白蛋白微球(5一Fu-MAMS)靶向治疗耐药裸鼠人胰腺癌模型的效果。方法构建人胰腺癌耐药细胞株(SW1990/Fu),建立裸鼠人胰腺癌耐药模型,选择适当的磁场,施加于肿瘤表面,瘤内注射mdr1ASON及5一Fu.MAMS,观察肿瘤生长,检测其对耐药裸鼠人胰腺癌的治疗效果。结果在外加磁场的磁导向作用下,5-Fu-MAMS能定位于肿瘤组织,联合mdr1ASON能显著抑制肿瘤生长,肿瘤体积抑制率达到85.00%,肿瘤重量抑制率达到87.74%,与其他组比较差异有统计学意义(P〈0.01)。结论辐射促转染的mdr1ASON联合磁性载药微球对肿瘤细胞具有较好的耐药逆转作用。 Objective To investigate the reversal the muhidrug resisitanee (MDR) by MDR gene mdrl antisense oligodeoxynueletdes (ASON) and 5-fluorouraeil magnetie albumin miserospheres (5-Fu- MAMS) magnetic targeted therapy the human pancreatic cancer in nude mouse model. Methods To construct SW1990/Fu and nude mice experimental model, to investigate the targeted therapy effects of mdrlASON and 5-Fu-MAMS. Results 5-Fu-MAMS magnetic response was good, its could be well localized in the tumor tissue and markedly inhibit the growth of tumor. The inhibitory rate of tumor size was 85.00%, and that of tumor weight 87.74%. which can effectively degrade proliferating index and accelerate cell death of tumor cell. There were significant differences as compared with other groups(P 〈 0. 01 ). Conclusion Mdrl ASON and 5-Fu-MAMS had outstanding reverse effect drug fast on human pancreatic carcinoma model in nude mice.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第1期23-25,共3页 Chinese Journal of Experimental Surgery
基金 贵州省省长基金资助项目[黔省专合字(2006)62号]
关键词 反义寡核苷酸 5-氟尿嘧啶 磁性白蛋白微球 胰腺癌 mdrlASON 5-fluorouracil Magnetic albumin miscrospheres Pancreatic carcinoma
  • 相关文献

参考文献7

二级参考文献31

  • 1吴阿富,彭道兴,黄欣欣,吴光华,陈国璋,戚文彬.磁性微球中5-Fu释放液的紧外分光光度法测定[J].现代应用药学,1995,12(3):32-35. 被引量:2
  • 2Lin W, Garnett MC,Schacht E, et al. Preparation and in vitro characterization of HSA-mPEG nanoparticles. Int J Pharm, 1999,189 : 161 - 170. 被引量:1
  • 3Widder K, Flouret G, Senyei A. Magnetic micro-spheres: synthesis of a novel parenteral drug carrier Pharm Sci, 1979,68 :79492. 被引量:1
  • 4Sugibayashi K, Morimoto Y, Nadai T, et al. Drug-carrier property of albumin microspheres in chemotherapy. Ⅱ. Preparation and tissue distribution in mice of microsphere-entrapped 5-fluorouracil. Chem Pharm Bull, 1979,27:204-209. 被引量:1
  • 5Allemanne E,Brasseur N,Benrezzak O,et al. PEG-Coated poly( lacticacid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours. Phann Pharmacol, 1995, 47:382-387. 被引量:1
  • 6Brlgger I, Dubemet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev ,2002,54:631-651. 被引量:1
  • 7Hioki Y, Masaji T, Hironobu O, et al. Locoregional chemotherapy for patients with pancreatic cancer intr-arterial adjuvant chemotherapy after pancreatectomy with portal vein reseaction. Pancreas,2002,25:366-372. 被引量:1
  • 8Hawes RH, Xiong Q, Waxman I, et al. A multispeciality approach to the diagnosis and management of pancreatic cancer. Am J GastroenteroI,2000:95:17. 被引量:1
  • 9Hioki Y, Masaji T, Hironobu O, et al. Locoregional chemotherapy for patients with pancreatic cancer intr arterial adjuvant chemotherapy after pancreatectomy with portal vein reseac tion. Pancreas, 2002,25 : 366-372. 被引量:1
  • 10Hawes RH, Xiong Q, Waxman I, et al. A multispeciality approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol, 2000,95 : 17. 被引量:1

共引文献15

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部